1 / 9

Allergy Diagnostics And Therapeutics Market Size, Share, Growth and Forecast to 2022 | Hexa Research

The growth of this market is fueled by the rise in the number of children below 14 years of age who are at greater risk of developing allergic diseases and disorders.

Carrol
Download Presentation

Allergy Diagnostics And Therapeutics Market Size, Share, Growth and Forecast to 2022 | Hexa Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst To a Lucrative Business Allergy Diagnostics And Therapeutics Market Analysis, Size, Share, Growth and Forecast to 2022 | Hexa Research “Global allergy diagnostics and therapeutics market is expected to witness significant growth at a CAGR of over 12% over the forecast period.” The Global Allergy Diagnostics And Therapeutics Market is anticipated to grow at a CAGR exceeding 12% during the forecast period (2016 to 2022). This attributes to the problem of environmental pollution and high incidence of allergic diseases. The probability of children below 14 years of age being afflicted with chronic allergies is a prominent factor that fuels industry demand. Frequent need for in-vitro blood tests may drive this market over the forecast period. Widespread adoption of diagnostics for treating inhaled allergies caused by air pollution could significantly contribute to demand. Nowadays, people are highly susceptible to allergies because of changing lifestyles, unhealthy dietary patterns, and urbanization. The worldwide allergy diagnostics and therapeutics market is categorized on the basis of products, type of allergens, end uses, tests, drug classes, and geographies. On the basis of products, the segments are services, consumables, and instruments. Immunoassay analyzers, luminometers, and other diagnostic devices are few of the commonly used equipment. Popularity of immunoassay analyzers is by far the highest in most developing economies of the world. Browse Details of Report@ https://www.hexaresearch.com/research-report/allergy-diagnostic-market Follow Us:

  2. Your Catalyst To a Lucrative Business Various types of allergens are drug allergens, inhaled allergens, food allergens, and others. Inhaled allergens held the highest industry share over the past couple of years because of numerous cases of air pollution based allergies. Based on end uses, the industry is trifurcated into diagnostics laboratories, and academic research institutes. Types of tests mainly include the following: in-vitro, patch, intradermal, skin prick, and in vivo. As per drug classes, the divisions are immunotherapy, autoinjectable epinephrine, immunomodulators, decongestants, nasal anticholinergics, leukotriene inhibitors, mast cell stabilizers, corticosteroids, and antihistamines. Geographically, the worldwide allergy diagnostics and therapeutics market is divided into Asia Pacific, Europe, North America, Latin America, and the Middle East & Africa. Over the past couple of years, North America has been dominating the global market in terms of revenue earnings. The region may continue leading the industry over the forecast period. Growing acceptance of in vitro blood tests, awareness about allergy diagnostics, and rising cases of allergic respiratory anomalies are drivers of this region. Europe is expected to register a high rate of growth because the region boasts of a mature pharmaceuticals industry. Surging demand for therapeutics is also a prominent regional driver. Other factors are rising cases allergic conditions and a rapidly expanding geriatric population. Asia Pacific may expand rapidly till 2022 owing to a rapidly developing medical infrastructure and surging demand for minimally invasive diagnostics solutions. The global allergy diagnostics and therapeutics market is a highly fragmented one with a host of companies continuously striving towards larger market shares. Lincoln Diagnostics, Siemens Healthcare, Hitachi Chemical Diagnostics, Alcon Laboratories, and Hycor Biomedical are some of the prominent competitors operating in the global market. In May 2016, Thermo Fisher Scientific licensed ProBioGen AG’s GlymaxX® technology for the development of allergy diagnostics. ProBioGen AG is a Germany based CDMO (contract development and manufacturing organization) & technology provider. Its key areas of focus are GMP production of biopharmaceuticals, process development, and cell lining engineering. The GlymaxX® technology yields antibodies with lower fucose content, is applicable to different types of species, needs no culture additives, and can even lead to enhanced productivity. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry Follow Us:

  3. Your Catalyst To a Lucrative Business Table of Content of Allergy Diagnostics And Therapeutics Market Chapter 1 Methodology and Scope 1.1 Country wise market calculation 1.2 Region based segment share calculation 1.3 Primary Sources 1.4 List of secondary sources Chapter 2 Executive Summary Chapter 3 Allergy Diagnostics Industry Outlook 3.1 Market segmentation 3.2 Market size and growth prospects 3.3 Allergy Diagnostics: Market dynamics 3.3.1 Market driver analysis 3.3.1.1 Increasing incidences of allergy diseases 3.3.1.2 Increasing demand for IVD tests for allergy diagnosis 3.3.1.3 Introduction of technologically advance allergy diagnostics products 3.3.1.4 Growing healthcare expenditure triggering development of effective allergy diagnostic & therapeutic products 3.3.2 Market restraint analysis 3.3.2.1 Low adoption and penetration in developing countries due to high cost of technology 3.3.2.2 Presence of ambiguous regulatory framework 3.4 Industry analysis - Porter’s 3.5 Key Opportunities Prioritized & Platform Positioning 3.5.1 Key Opportunities Prioritized 3.6 Allergy Diagnostics Competitive Landscape, 2014 3.6.1 Company Market Share Analysis, 2014 3.6.2 Competitive Landscape: Market Position Analysis 3.7 Pipleline Aanlysis: Allergy Therapeutics 3.8 Allergy Diagnostics- PESTEL analysis Chapter 4 Allergy Diagnostics Product Outlook 4.1 Allergy diagnostics market share, by product, 2014 & 2022 4.2 Instruments Follow Us:

  4. Your Catalyst To a Lucrative Business 4.2.1 Instruments market, 2012 - 2022 (USD Million) 4.3 Consumables 4.3.1 Consumables market, 2012 - 2022 (USD Million) 4.4 Services 4.4.1 Services market, 2012 - 2022 (USD Million) Chapter 5 Allergy Diagnostics Allergen Type Outlook 5.1 Allergy diagnostics market share, by allergen type, 2014 & 2022 5.2 Food Allergen 5.2.1 Food Allergen market, 2012 - 2022 (USD Million) 5.3 Inhaled Allergen 5.3.1 Inhaled allergen market, 2012 - 2022 (USD Million) 5.4 Drug Allergen 5.4.1 Drug allergen market, 2012 - 2022 (USD Million) 5.5 Other 5.5.1 Other market, 2012 - 2022 (USD Million) Chapter 6 Allergy Diagnostics End-use Outlook 6.1 Global allergy diagnostics market share, by end-use, 2014 & 2022 6.2 Academic Research Institutes 6.2.1 Academic research institutes market, 2012 - 2022 (USD Million) 6.3 Hospitals 6.3.1 Hospitals market, 2012 - 2022 (USD Million) 6.4 Diagnostic Laboratories 6.4.1 Diagnostic laboratories market, 2012 - 2022 (USD Million) Chapter 7 Allergy Diagnostics Test Outlook 7.1 Global allergy diagnostics market share, by test, 2014 & 2022 7.2 In vivo test 7.2.1 In vivo test market, 2012 - 2022 (USD Million) 7.2.2 Skin prick test 7.2.2.1 Skin prick test market, 2012 - 2022 (USD Million) 7.2.3 Intradermal test 7.2.3.1 Intradermal test market, 2012 - 2022 (USD Million) 7.2.4 Patch test 7.2.4.1 Patch test market, 2012 - 2022 (USD Million) Follow Us:

  5. Your Catalyst To a Lucrative Business 7.3 In vitro test 7.3.1 In vitro test market, 2012 - 2022 (USD Million) Chapter 8 Allergy Therapeutics Drug Class Outlook 8.1 Global allergy therapeutics market share, by drug class, 2014 & 2022 8.2 Antihistamines 8.2.1 Antihistamines market, 2012 - 2022 (USD Million) 8.3 Corticosteroids 8.3.1 Corticosteroids market, 2012 - 2022 (USD Million) 8.4 Mast Cell Stabilizers 8.4.1 Mast Cell Stabilizers market, 2012 - 2022 (USD Million) 8.5 Leukotriene Inhibitors 8.5.1 Leukotriene Inhibitors market, 2012 - 2022 (USD Million) 8.6 Nasal anticholinergics 8.6.1 Nasal anticholinergics market, 2012 - 2022 (USD Million) 8.7 Decongestants 8.7.1 Decongestants market, 2012 - 2022 (USD Million) 8.8 Immunomodulators 8.8.1 Immunomodulators market, 2012 - 2022 (USD Million) 8.9 Autoinjectable Epinephrine 8.9.1 Autoinjectable epinephrine market, 2012 - 2022 (USD Million) 8.10 Immunotherapy 8.10.1 Immunotherapy market, 2012 - 2022 (USD Million) Chapter 9 Allergy Diagnostics Regional Outlook 9.1 Allergy Diagnostics market share, by region, 2014 & 2022 9.2 North America 9.2.1 North America allergy diagnostics market, 2012 - 2022 (USD Million) 9.2.2 North America allergy therapeutics market, 2012 - 2022 (USD Million) 9.2.3 U.S. 9.2.3.1 U.S. Allergy Diagnostics market, 2012 - 2022 (USD Million) 9.2.3.2 U.S. allergy therapeutics market, 2012 - 2022 (USD Million) 9.3 Europe 9.3.1 Europe Allergy Diagnostics market, 2012 - 2022 (USD Million) 9.3.2 Europe allergy therapeutics market, 2012 - 2022 (USD Million) 9.3.3 Germany Follow Us:

  6. Your Catalyst To a Lucrative Business 9.3.3.1 Germany Allergy Diagnostics market, 2012 - 2022 (USD Million) 9.3.3.2 Germany allergy therapeutics market, 2012 - 2022 (USD Million) 9.3.4 UK 9.3.4.1 UK allergy diagnostics market, 2012 - 2022 (USD Million) 9.3.4.2 UK allergy therapeutics market, 2012 - 2022 (USD Million) 9.4 Asia Pacific 9.4.1 Asia Pacific allergy diagnostics market, 2012 - 2022 (USD Million) 9.4.2 Asia Pacific allergy therapeutics market, 2012 - 2022 (USD Million) 9.4.3 Japan 9.4.3.1 Japan allergy diagnostics market, 2012 - 2022 (USD Million) 9.4.3.2 Japan allergy therapeutics market, 2012 - 2022 (USD Million) 9.4.4 China 9.4.4.1 China allergy diagnostics market, 2012 - 2022 (USD Million) 9.4.4.2 China allergy therapeutics market, 2012 - 2022 (USD Million) 9.5 Latin America 9.5.1 Latin America allergy diagnostics market, 2012 - 2022 (USD Million) 9.5.2 Latin America allergy therapeutics market, 2012 - 2022 (USD Million) 9.5.3 Brazil 9.5.3.1 Brazil allergy diagnostics market, 2012 - 2022 (USD Million) 9.5.3.2 Brazil allergy therapeutics market, 2012 - 2022 (USD Million) 9.6 MEA 9.6.1 MEA allergy diagnostics market, 2012 - 2022 (USD Million) 9.6.2 MEA allergy therapeutics market, 2012 - 2022 (USD Million) 9.6.3 South Africa 9.6.3.1 South Africa allergy diagnostics market, 2012 - 2022 (USD Million) 9.6.3.2 South Africa allergy therapeutics market, 2012 - 2022 (USD Million) Chapter 10 Competitive Landscape 10.1 bioMerieux 10.1.1 Company Overview 10.1.2 Financial Performance 10.1.3 Product Benchmarking 10.1.4 Strategic Initiatives 10.2 Danaher Corporation 10.2.1 Company Overview 10.2.2 Beckman Coulter Follow Us:

  7. Your Catalyst To a Lucrative Business 10.2.3 Financial Performance 10.2.4 Product Benchmarking 10.2.5 Strategic Initiatives 10.3 Thermo Fisher Scientific 10.3.1 Company Overview 10.3.2 Financial Performance 10.3.3 Product Benchmarking 10.3.4 Strategic Initiatives 10.4 Stallergenes Greer 10.4.1 Company Overview 10.4.2 Financial Performance 10.4.3 Product Benchmarking 10.4.4 Strategic Initiatives 10.5 Hitachi Chemical Diagnostics 10.5.1 Company Overview 10.5.2 Financial Performance 10.5.3 Product Benchmarking 10.5.4 Strategic Initiatives 10.6 Siemens Healthcare 10.6.1 Company Overview 10.6.2 Financial Performance 10.6.3 Service Benchmarking 10.6.4 Strategic Initiatives 10.7 Omega Diagnostics 10.7.1 Company Overview 10.7.2 Financial Performance 10.7.3 Product Benchmarking 10.7.4 Strategic Initiatives 10.8 Hycor Biomedical 10.8.1 Company Overview 10.8.2 Financial Performance 10.8.3 Product Benchmarking 10.8.4 Strategic Initiatives 10.9 Lincoln Diagnostics 10.9.1 Company Overview 10.9.2 Financial Performance Follow Us:

  8. Your Catalyst To a Lucrative Business 10.9.3 Product Benchmarking 10.9.4 Strategic Initiatives 10.10 HOB Biotech Group 10.10.1 Company Overview 10.10.2 Financial Performance 10.10.3 Product Benchmarking 10.10.4 Strategic Initiatives 10.11 Alcon Laboratories, Inc. 10.11.1 Company Overview 10.11.2 Financial Performance 10.11.3 Product Benchmarking 10.11.4 Strategic Initiatives Follow Us:

  9. Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Visit Our Blog - hexaresearch1.blogspot.com Follow Us:

More Related